510(k) K150144
K150144 is an FDA 510(k) premarket notification submitted by Affinity Biologicals, Inc. for the device "VisuCon-F Low Fibrinogen Control Plasma". The FDA issued a decision of Substantially Equivalent on March 6, 2016. The device falls under product code GGN (Plasma, Coagulation Control), a Class II device regulated under 21 CFR 864.5425. Affinity Biologicals, Inc. has at least 4 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 6, 2016
- Date Received
- January 22, 2015
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Plasma, Coagulation Control
- Device Class
- Class II
- Regulation Number
- 864.5425
- Review Panel
- HE
- Submission Type